| ABSTRACT Objective:To investigate the clinical distribution characteristics, risk factors and bacterial drug resistance of the blood stream infection of Acinetobacter, and provide guidance for clinical rational drug use and control of hospital infection.Methods:A retrospective analysis in 2011 2014 patients with acinetobacter baumannii bloodstream infections during the period of clinical and microbiological data，included basic information of patients, the clinical feature, the underlying diseases, microbilogical characteristics and usage of antimicrobial agents, etc. Results:55 patients with acinetobacter baumannii bloodstream infections in the elderly accounted for 47.27%; Basic diseases mainly for cerebrovascular disease 19 cases (34.55%), diabetes 15 cases (27.27%). Distribution department for the most intensive medicine, accounted for 16.36%, 18 cases underwent the central venous catheter. All strains to participate in screening of antimicrobial agents, the third generation cephalosporin resistant rate is highest, cefoperazone shu ba resistance to a minimum.Conclusion:Acinetobacter baumannii bloodstream infection multiple in critically ill patients, suspected with Acinetobacter baumannii bloodstream infections in patients with blood culture, empirical selection of cefoperazone sodium and sulbactam sodium. Meanwhile we should pay attention to the prevention and control of hospital infection. |
